Tilray ( TLRY ) announced its entry into US cannabis markets today as Trump signed an EO to reschedule cannabis. The Executive Order directs the federal government to finish the process of reschedulingWelcome to the home of The Cannabis Report. I cover the cannabis sector and other sectors. I am most interested in technical stock analysis, option strategies, small cap strategies, and emerging markets. Feel free to contact me with any questions about publicly traded stocks in the cannabis industry.Analyst’s ...

A leveraged ETF that gives investors exposure to the American cannabis industry looks set to soar following President Donald Trump’s executive order directing the easing of federal restrictions on the psychoactive substance. The AdvisorShares MSOS Daily Leveraged ETF (NYSE:MSOX) , as the name suggests, is a leveraged fund that gives investors exposure to two times the daily total return of the AdvisorShares Pure US Cannabis ETF (NYSE:MSOS) , which is seeing a lot of activity amid this major regulatory shift ...

行业监管动态 - 美国总统发布行政命令 指示相关部门启动将大麻从《管制物质法案》附表I重新分类至附表III的程序[1] - 重新分类将使大麻脱离联邦法律下最严格的类别 从而改善持牌运营商的经营经济性 促进医学研究扩展 并推动受监管大麻行业的进一步正常化[2] 对公司财务与运营的直接影响 - 附表III分类将消除280E税收负担 从而改善公司现金流 并允许其更有效地对人员、设施和长期增长进行再投资[3] - 移除280E条款将强化整个行业的资产负债表 并为类似公司提供更多增长资本以加速扩张计划[3] - 重新分类有可能实质性改善整个大麻行业的资本获取渠道 监管清晰度的提升可能吸引更多机构投资者参与 扩大潜在贷款方范围 并降低整体资本成本[4] - 更低的资本成本将为公司创造重要机会 以资助增长、投资基础设施并更高效地扩大运营规模[4] 公司业务与战略定位 - 公司拥有先进的提取、制造和种植设施 为加利福尼亚州和纽约州的持牌品牌提供服务[3] - 公司在Salisbury Canyon Ranch拥有一项休眠的100英亩大麻许可证 并运营一个世界级的提取平台 能够生产高纯度、合规的大麻素产品[5] - 随着与大麻衍生大麻素和医疗报销相关的监管框架发展 公司认为其基础设施提供了战略上的灵活性[5] - 公司是一家垂直整合的多州大麻运营商 专注于提取、制造和种植业务 其在Salisbury Canyon Ranch的大型种植项目及纽约加工业务使其在受监管市场中具备可持续增长的定位[6] 潜在未来监管发展 - 除了重新分类 公司正密切关注与大麻衍生大麻素相关的联邦进展 以及某些CBD产品可能纳入医疗保险覆盖范围的事宜[4] - 医疗保险和医疗补助服务中心预计最早在2026年制定试点计划 允许部分医疗保险患者获得基于大麻素的疗法 包括CBD[4]

VANCOUVER, British Columbia, Dec. 18, 2025 (GLOBE NEWSWIRE) -- LEEF Brands, Inc. (CSE: LEEF, OTCQB: LEEEF) (“LEEF” or the “Company”), a leading multi-state operator, today commented on the issuance of an executive order by President Donald Trump directing agencies to begin the rescheduling of cannabis under the U.S. Controlled Substances Act. The executive order initiates the reclassification of cannabis from Schedule I to Schedule III, removing it from the most restrictive category under federal law. This ...

Schedule III action affirms medical legitimacy and advances a more regulated national cannabis marketTAMPA, Fla., Dec. 18, 2025 (GLOBE NEWSWIRE) -- FLUENT Corp. (CSE: FNT.U) (OTCQB: CNTMF) (“FLUENT” or the “Company”), today applauds the historic federal action directing the rescheduling of cannabis from Schedule I to Schedule III under the Controlled Substances Act, a landmark policy shift that formally recognizes cannabis’s accepted medical use and represents a critical step toward a more rational and regu ...

MARYSVILLE, Ohio, Dec. 18, 2025 (GLOBE NEWSWIRE) -- The Scotts Miracle-Gro Company (NYSE: SMG), the leading marketer of branded consumer lawn and garden products in North America, today expressed support for President Trump’s executive order to reschedule cannabis from a Schedule I to Schedule III drug. “With 39 states already legalizing cannabis in some form, rescheduling to a lower level drug on the federal level has been long overdue,” said Chairman and CEO Jim Hagedorn. “President Trump deserves credit ...

CEO says move enhances company’s broader growth strategyMARYSVILLE, Ohio, Dec. 18, 2025 (GLOBE NEWSWIRE) -- The Scotts Miracle-Gro Company (NYSE: SMG), the leading marketer of branded consumer lawn and garden products in North America, today expressed support for President Trump’s executive order to reschedule cannabis from a Schedule I to Schedule III drug. “With 39 states already legalizing cannabis in some form, rescheduling to a lower level drug on the federal level has been long overdue,” said Chairman ...

Trump Administration's Rescheduling Opens New Avenues for Research, Medical Advancement, and Investment This media advisory contains forward-looking statements and forward-looking information within the meaning of applicable securities laws. These statements relate to future events or future performance. All statements other than statements of historical fact may be forward–looking statements or information. Generally, forward-looking statements and information may be identified by the use of forward-lookin ...

CHICAGO--(BUSINESS WIRE)--Cresco Labs Inc. (CSE: CL) (OTCQX: CRLBF) (FSE: 6CQ) ("Cresco Labs†or the "Company†), today issued a statement on behalf of Cresco Labs CEO Charlie Bachtell following President Trump's action to reschedule cannabis from a Schedule I to Schedule III substance under the Controlled Substances Act. "Today marks the most consequential moment in the history of U.S. cannabis. The decision to move cannabis from Schedule I to Schedule III will be a cultural turning point, ackn. ...

Verano’s active operations span 13 states, comprised of 158 dispensaries operating under the Zen Leaf™ and MÜV™ retail banners, and 15 cultivation and processing facilities with more than 1.1 million square feet of cultivation capacity CHICAGO, Dec. 18, 2025 (GLOBE NEWSWIRE) -- Verano Holdings Corp. (Cboe CA: VRNO) (OTCQX: VRNO) (“Verano” or the “Company”), a leading multi-state cannabis company, celebrates today’s historic announcement that President Donald Trump has issued an Executive Order directing the ...